VEGFA and cancer: This research is among the first to consider the effect of hit compounds on multiple diseases, which represents a vital step toward developing small-molecule inhibitors of the VEGF-A/NRP1 signalling for the treatment of neuropathic pain, cancer, and potentially also of SARS-CoV-2 infections.